Quarterly report pursuant to Section 13 or 15(d)

Revenue Recognition (Tables)

v3.20.2
Revenue Recognition (Tables)
9 Months Ended
Sep. 30, 2020
Revenue Recognition [Abstract]  
Schedule of revenue recognition
    Three Months Ended September 30,  
    2020     2019  
Functional neurosurgery navigation                
Disposable products   $ 1,840,060     $ 1,854,251  
Therapy                
Disposable products           64,095  
Services           50,000  
Subtotal – therapy revenue           114,095  
Biologics and drug delivery                
Disposable products     419,946       491,257  
Services     1,054,622       72,500  
Subtotal – biologics and drug delivery revenue     1,474,568       563,757  
Capital equipment and software                
Systems and software products     73,544       184,825  
Services     131,015       210,538  
Subtotal – capital equipment and software revenue     204,559       395,363  
Total revenue   $ 3,519,187     $ 2,927,466  

 

    Nine Months Ended September 30,  
    2020     2019  
Functional neurosurgery navigation                
Disposable products   $ 4,573,484     $ 5,212,460  
Therapy                
Disposable products     78,800       81,925  
Services     25,000       200,000  
Subtotal – therapy revenue     103,800       281,925  
Biologics and drug delivery                
Disposable products     1,000,276       957,673  
Services     2,646,050       338,112  
Subtotal – biologics and drug delivery revenue     3,646,326       1,295,785  
Capital equipment and software                
Systems and software products     377,445       700,517  
Services     411,508       515,695  
Subtotal – capital equipment and software revenue     788,953       1,216,212  
Total revenue   $ 9,112,563     $ 8,006,382